"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis

Kidney International

Volumn 48, Issue 3, 1995, Pages 851-859

  Toto, Robert D ^a   Mitchell, Helen C ^b   Smith, Ronald D ^b   Lee, Hing Chung ^b   Mcintire, Donald ^b   Pettinger, William A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029126288     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.361     Document Type: Article

References (35)

1. The National Institutes of Health U.S. Renal Data Systems Annual Report. U S Renal Data Systems 1993
2. BLYTHE WD, MADDUX FW: Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States form 1980-1986. Am J Kid Dis 28:33-37, 1991
3. MOYER JH, HEIDER C, PEVEY K, FORD RV: The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function. Am J Med 24:177-192, 1958
4. MAGEE JH, UNGER AM, RICHARDSON DW: Changes in renal function associated with drug or placebo therapy of human hypertension. Am J Med 36:795-804, 1964
5. SHULMAN NB, FORD CE, HALL WD, BLAUFOX D, SIMON D, LANGFORD HB, SCHNEIDER KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the Hypertension Detection and Follow-up study. Hypertension 13(Suppl I):I80-I93, 1989
6. BRECKENRIDGE A, DOLLERY CT, PARRY EHO: Prognosis of treated hypertension: Changes in life expectancy and causes of death between 1952 and 1967. Quart J Med 39:411-429, 1970
7. ROSTAND SG, BROWN G, KIRK KA, RUTSKY EA, DUSTAN HP: Renal insufficiency in treated essential hypertension. N Engl Med 320:684-688, 1988
8. WALKER GW, NEATON JD, CUTLER JA, NEUWIRTH R, COHEN JD: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. JAMA 268:3085-3091, 1992
9. ROSANSKY SJ, HOOVER DR, KING L, GIBSON J: The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 150:2073-2076, 1990
10. RELMAN AS: Race and end-stage renal disease. N Engl Med 306:1290-1291, 1982
11. ROSTAND SG, KIRK KA, RUTSKY EA, PATE BA: Racial differences in the incidence of treatment for end-stage renal disease. N Engl Med 306:1276-1279, 1982
12. WHELTON PK, KLAG MJ: Hypertension as a risk factor for renal disease. Hypertension 13(Suppl I):I19-I27, 1993
13. EGGERS PW, CONNERTON R, MCMULLAN M: The medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival. Health Care Fin Rev 5:69-88, 1984
14. MCCLELLAN W, TUTTLE E, ISSA A: Racial differences in the incidence of hypertensive end-stage renal disease are not entirely explained by differences in the prevalence of hypertension. Am J Kid Dis 12:285-290, 1988
15. PETTINGER WA, MITCHELL HE: Minoxidil - An alternative to nephrectomy for refractory hypertension. N Engl J Med 289:167-173, 1973
16. MITCHELL HE, GRAHAM MR, PETTINGER WA: Renal function during long-term treatment of hypertension with minoxidil: Comparison of benign and malignant hypertension. Ann In Med 93:676-681, 1980
17. VETERANS ADMINISTRATION COOPERATIVE STUDY GROUP ON ANTIHYPERTENSIVE AGENTS: Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202:116-122, 1967
18. MULTIPLE RISK FACTOR INTERVENTION TRIAL RESEARCH GROUP: Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 248:1465-1467, 1982
19. MANAGEMENT COMMITTEE OF THE AUSTRALIAN THERAPEUTIC TRIAL IN MILD HYPERTENSION: Untreated mild hypertension: A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension. Lancet i:185-191, 1982
20. VETERANS ADMINISTRATION COOPERATIVE STUDY GROUP ON ANTIHYPERTENSIVE AGENTS: Effects of treatment on morbidity in hypertension III. Influence of age, diastolic pressure and prior cardiovascular disease; Further analysis of side effects. Circulation XLV:991-1003, 1972
21. National High Blood Pressure Education Program (NHBPEP) Working Group Report. Bethesda, US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990
22. LUKE RG: Can renal failure due to hypertension be prevented? Hypertension 18(Suppl 3):I139-I142, 1991
23. WOLFF FW, LINDEMAN RD: Effects of treatment in hypertension: Results of a controlled trial. J Chron Dis 19:227-240, 1966
24. BERGSTROM J, ALVESTRAND A, BUCHT H, GUTIERREZ A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-up and better blood pressure control. Clin Nephrol 25:1-6, 1986
25. PETTINGER WA, LEE HC, REISCH J, MITCHELL HC: Long-term improvement in renal function after short-term "strict" blood pressure control in hypertensive nephrosclerosis. Hypertension 89:766-772, 1989
26. PERNEGER TV, KLAG JJ, FELDMAN HI, WHELTON PK: Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA 269:1272-1277, 1993
27. ISRAELIT A, LONG DL, WHITE MG, HULL AR: Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. Kidney Int 4:346-349, 1973
28. LEVEY AS: Measurement of renal function in chronic renal disease. Kidney Int 38:167-184, 1990
29. LAIRD NM, WARE JH: Random-effects models for longitudinal data. Biometrics 38:963-974, 1982
30. KLAHR S, LEVEY A, BECK G, CAGGIULA A, HUNSICKER L, KUSEK J, STRIKER G: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl Med 330:877-884, 1994
31. LINDEMAN RD, TOBIN JD, SHOCK NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861-868, 1984
32. EASTERLING RE: Racial factors in the incidence and causation of end-stage renal disease (ESRD). Trans Am Soc Artif Intern Organs 23:28-33, 1977
33. SHULMAN NB: Epidemiology of hypertension in blacks, in Hypertension in Blacks: Epidemiology, Pathophysiology and Treatment, edited by HALL WD, SAUNDERS E, SHULMAN NB, Chicago, New York Medical Publishers, 1985, p 115
34. BRAZY PC, STEAD WW, FITZWILLIAM JF: Progression of renal insufficiency: Role of blood pressure. Kidney Int 35:670-674, 1989
35. ZUCCCHELLI P, ZUCCALA A, BORGHI M, FUSAROLI M, SASDELLI M, STALLONE C, SANNA G, GAGGI R: Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 42:452-458, 1992